Yiling Pharmaceutical Inc. announced that it will receive $7,250,000 in a round of equity funding from existing investor Shijiazhuang Yiling Pharmaceutical Co., Ltd. on March 17, 2015. Post the closing of the transaction, the registered capital of the company will increase to $8,300,000.